March 29, 2025
(Not financial advice)
Price was rejected from GB47 ($86,935) — a Mitigation Block. Internal liquidity (ITL) has been swept. Now price is moving toward external targets.
Current Outlook:
GB29 ($76,157) – This is a Liquidity Void, but it’s also the end of a Goldbach pathway. That means we could see a short-term reaction or pause here. It’s not expected to hold long-term unless momentum shifts, but it’s still a key level to watch.
GB11 ($65,660) – If GB29 fails to hold, GB11 becomes the next logical target. It’s a strong Order Block with added confluence from the 1 Standard Deviation (SDVT) level and Fibonacci projection.
Summary:
Bias: Still bearish
Watching for possible reaction at GB29
GB11 is the key support if GB29 gives way
Reclaiming GB47 would flip the bias
(Not financial advice)
Price was rejected from GB47 ($86,935) — a Mitigation Block. Internal liquidity (ITL) has been swept. Now price is moving toward external targets.
Current Outlook:
GB29 ($76,157) – This is a Liquidity Void, but it’s also the end of a Goldbach pathway. That means we could see a short-term reaction or pause here. It’s not expected to hold long-term unless momentum shifts, but it’s still a key level to watch.
GB11 ($65,660) – If GB29 fails to hold, GB11 becomes the next logical target. It’s a strong Order Block with added confluence from the 1 Standard Deviation (SDVT) level and Fibonacci projection.
Summary:
Bias: Still bearish
Watching for possible reaction at GB29
GB11 is the key support if GB29 gives way
Reclaiming GB47 would flip the bias
Note
Trade active
GB29 ($76,157) support
Lord MEDZ
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Lord MEDZ
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.